|
Nature reviews. Cancer, Vol. 9, No. 1. (01 January 2009), pp. 28-39.
posted by
7 people
LeilaA
saradtc
kokphinchooi
TimRooney
sschurer
renatomilani
guhjy
AbstractDeregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiological constraints on growth and survival. To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small molecule inhibitors for a host of other kinases that are implicated in cancer and other diseases. Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to ... | |
|
Science (New York, N.Y.), Vol. 298, No. 5600. (6 December 2002), pp. 1912-1934.
posted by
17 people
jtcribbs
LeilaA
guhjy
saradtc
nedwards
nzm
catcremona
Yanno
ceolas
tjimenez
kuhn
aqeel
lenov
Evangelia
renatomilani
taten
daed
AbstractWe have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences. This provides a starting point for comprehensive analysis of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome analysis through a focus on one large gene family. We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described ... | |
|
J. Biol. Chem., Vol. 283, No. 22. (30 May 2008), pp. 15142-15151.
AbstractHspA, a member of the GroES chaperonin family, is a small protein found in Helicobacter pylori with a unique histidine- and cysteine-rich domain at the C terminus. In this work, we overexpressed, purified, and characterized this protein both in vitro and in vivo. The apo form of the protein binds 2.10 +/- 0.07 Ni2+ or 1.98 +/- 0.08 Bi3+ ions/monomer with a dissociation constant (Kd) of 1.1 or 5.9 x 10-19 microM, respectively. Importantly, Ni2+ can reversibly bind to the protein, ... | |
|
J. Biol. Chem., Vol. 282, No. 37. (14 September 2007), pp. 26775-26785.
posted by
2 people
Copper_Calcio
csjonline
AbstractThe Ctr1 family of integral membrane proteins is necessary for high affinity copper uptake in eukaryotes. Ctr1 is also involved in cellular accumulation of cisplatin, a platinum-based anticancer drug. Although the physiological role of Ctr1 has been revealed, the mechanism of action of Ctr1 remains to be elucidated. To gain a better understanding of Ctr1-mediated copper and cisplatin transport, we have monitored molecular dynamics and transport activities of yeast Saccharomyces cerevisiae Ctr1 and its mutant alleles. Co-expression of functional Ctr1 monomers ... | |
|
J. Biol. Chem., Vol. 283, No. 44. (31 October 2008), pp. 30184-30192.
by Eduard Bitto, Craig A. Bingman, Lenka Bittova, et al.Dmitry A. Kondrashov, Ryan M. Bannen, Brian G. Fox, John L. Markley, George N. Phillips
AbstractIron-sulfur proteins play indispensable roles in a broad range of biochemical processes. The biogenesis of iron-sulfur proteins is a complex process that has become a subject of extensive research. The final step of iron-sulfur protein assembly involves transfer of an iron-sulfur cluster from a cluster-donor to a cluster-acceptor protein. This process is facilitated by a specialized chaperone system, which consists of a molecular chaperone from the Hsc70 family and a co-chaperone of the J-domain family. The 3.0A crystal structure of a ... | |
|
The Journal of biological chemistry (4 November 2008)
by Andrew James J. Mason, Wardi Moussaoui, Tamer Abdelrahman, et al.Alyae Boukhari, Philippe Bertani, Arnaud Marquette, Peiman Shooshtarizaheh, Gilles Moulay, Nelly Boehm, Bernard Guerold, Ruairidh James H J. Sawers, Antoine Kichler, Marie-Hélène H. Metz-Boutigue, Ermanno Candofi, Gilles Prévost, Burkhard Bechinger
posted by
2 people
paulschlesinger
csjonline
AbstractDesigned histidine rich amphipathic cationic peptides such as LAH4 have enhanced membrane disruption and antibiotic properties when the peptide adopts an alignment parallel to the membrane surface. Whereas this was previously achieved by lowering the pH, here we have designed a new generation of histidine rich peptides that adopt a surface alignment at neutral pH. In vitro, this new generation of peptides are powerful antibiotics in terms of the concentrations required for antibiotic activity, the spectrum of target bacteria, fungi and ... | |
|
Proceedings of the National Academy of Sciences, Vol. 105, No. 32. (2008), pp. 11158-11163.
Abstract10.1073/pnas.0802928105 It is unclear how the human copper (Cu) chaperone Atox1 delivers Cu to metal-binding domains of Wilson and Menkes disease proteins in the cytoplasm. To begin to address this problem, we have characterized Cu(I) release from wild-type Atox1 and two point mutants (MetAla and LysAla). The dynamics of Cu(I) displacement from holo-Atox1 were measured by using the Cu(I) chelator bicinchonic acid (BCA) as a metal acceptor. BCA removes Cu(I) from Atox1 in a three-step process involving the bimolecular formation of ... | |
|
FEBS Letters, Vol. 381, No. 1-2. (26 February 1996), pp. 161-164.
AbstractUsing atomic force microscopy (AFM) in aqueous solution, we show that the surface structure of the oligomeric GroES can be obtained up to 10 Å resolution. The seven subunits of the heptamer were well resolved without image averaging. The overall dimension of the GroES heptamer was 8.4±0.4 nm in diameter and 3.0±0.3 nm high. However, the AFM images further suggest that there is a central protrusion of 0.8±0.2 nm high and 4.5±0.4 nm in diameter on one side of GroES which ... | |
|
BMC Bioinformatics, Vol. 8, No. 1. (2007), 487.
by Egon Willighagen, Noel O'Boyle, Harini Gopalakrishnan, et al.Dazhi Jiao, Rajarshi Guha, Christoph Steinbeck, David Wild
posted by
25 people
lmichan
perkeo
Journal picks
walshtp
inthemiddle
guillermosanchez3
kshameer
Yanno
daforerog
csjonline
egonw
druvus
Roswell Cancer Crosstalk
Zephyrus
guhjy
dullhunk
sleepingcell
neils
laughcry
Gaetan
sci91078
mircea
craigecht
mattions
wisdom_love
AbstractBACKGROUND:The web has seen an explosion of chemistry and biology related resources in the last 15 years: thousands of scientific journals, databases, wikis, blogs and resources are available with a wide variety of types of information. There is a huge need to aggregate and organise this information. However, the sheer number of resources makes it unrealistic to link them all in a centralised manner. Instead, search engines to find information in those resources flourish, and formal languages like Resource Description Framework ... | |
|
Infect. Immun., Vol. 69, No. 9. (1 September 2001), pp. 5914-5920.
AbstractHelicobacter hepaticus causes disease in the liver and lower intestinal tract of mice. It is strongly urease positive, although it does not live in an acidic environment. The H. hepaticus urease gene cluster was expressed in Escherichia coli with and without coexpression of the Helicobacter pylori nickel transporter NixA. As for H. pylori, it was difficult to obtain enzymatic activity from recombinant H. hepaticus urease; special conditions including NiCl2 supplementation were required. The H. hepaticus urease cluster contains a homolog of ... | |
|
Science (16 August 2007), 1142819.
AbstractThe structural mechanisms by which proteins have evolved new functions are known only indirectly. We report x-ray crystal structures of a resurrected ancestral proteinthe ~450 million-year-old precursor of vertebrate glucocorticoid (GR) and mineralocorticoid (MR) receptors. Using structural, phylogenetic, and functional analysis, we identify the specific set of historical mutations that recapitulate the evolution of GR's hormone specificity from an MR-like ancestor. These substitutions repositioned crucial residues to create new receptor-ligand and intraprotein contacts. Strong epistatic interactions occur because one substitution changes ... | |
|
Briefings in bioinformatics, Vol. 3, No. 3. (September 2002), pp. 296-302.
AbstractBioinformatics research is often difficult to do with commercial software. The Open Source BioPerl, BioPython and Biojava projects provide toolkits with multiple functionality that make it easier to create customised pipelines or analysis. This review briefly compares the quirks of the underlying languages and the functionality, documentation, utility and relative advantages of the Bio counterparts, particularly from the point of view of the beginning biologist programmer. ... | |
|
Nature Biotechnology, Vol. 27, No. 1. (04 January 2009), pp. 66-75.
by Joel Rozowsky, Ghia Euskirchen, Raymond K. Auerbach, et al.Zhengdong D. Zhang, Theodore Gibson, Robert Bjornson, Nicholas Carriero, Michael Snyder, Mark B. Gerstein
posted by
22 people
tobiasg82
bedo
hzoltan
fpattyn
gdb
huali
ewilban1
fenghezi
smiddha
jfr
bertelsen
JeremyZucker
cassj
inesdesantiago
dakelley
SIMR bioinformatics
ghattem
abizar
polivares
idonaldson
WanderingAengus
guhjy
AbstractChromatin immunoprecipitation (ChIP) followed by tag sequencing (ChIP-seq) using high-throughput next-generation instrumentation is fast, replacing chromatin immunoprecipitation followed by genome tiling array analysis (ChIP-chip) as the preferred approach for mapping of sites of transcription-factor binding and chromatin modification. Using two deeply sequenced data sets for human RNA polymerase II and STAT1, each with matching input-DNA controls, we describe a general scoring approach to address unique challenges in ChIP-seq data analysis. Our approach is based on the observation that sites of potential ... | |
|
Science, Vol. 323, No. 5912. (16 January 2009), pp. 401-404.
by Shin Sasaki, Cecilia C. Mello, Atsuko Shimada, et al.Yoichiro Nakatani, Shin-ichi Hashimoto, Masako Ogawa, Kouji Matsushima, Sam G. Gu, Masahiro Kasahara, Budrul Ahsan, Atsushi Sasaki, Taro Saito, Yutaka Suzuki, Sumio Sugano, Yuji Kohara, Hiroyuki Takeda, Andrew Fire, Shinichi Morishita
posted by
13 people
hagechouchin443
bpcusack
tprpip
gdb
fenghezi
ewilban1
benjaminsb
taroleo
jbhiatt
abizar
timflutre
djkt
pkonings
AbstractMight DNA sequence variation reflect germline genetic activity and underlying chromatin structure? We investigated this question using medaka (Japanese killifish, Oryzias latipes), by comparing the genomic sequences of two strains (Hd-rR and HNI) and by mapping [~]37.3 million nucleosome cores from Hd-rR blastulae and 11,654 representative transcription start sites from six embryonic stages. We observed a distinctive [~]200-base pair (bp) periodic pattern of genetic variation downstream of transcription start sites; the rate of insertions and deletions longer than 1 bp peaked ... | |
|
Bioinformatics, Vol. 24, No. 21. (1 November 2008), pp. 2431-2437.
posted by
21 people
hzoltan
gbenson
bozdagd
adijr
gdb
n00c
GeeSharpMinor
inesdesantiago
GustavoLacerda
cthachuk
guhjy
abizar
APRegier
natstreet
druvus
caseybrown
djkt
wisdom_love
umit
Neeperando
Stew
AbstractMotivation: The next generation sequencing technologies are generating billions of short reads daily. Resequencing and personalized medicine need much faster software to map these deep sequencing reads to a reference genome, to identify SNPs or rare transcripts. Results: We present a framework for how full sensitivity mapping can be done in the most efficient way, via spaced seeds. Using the framework, we have developed software called ZOOM, which is able to map the Illumina/Solexa reads of 15x coverage of a ... | |
|
Nature, Vol. 453, No. 7196. (5 June 2008), pp. 793-797.
by Yoshinori Kawamura, Kuniaki Saito, Taishin Kin, et al.Yukiteru Ono, Kiyoshi Asai, Takafumi Sunohara, Tomoko N. Okada, Mikiko C. Siomi, Haruhiko Siomi
AbstractRNA silencing is a conserved mechanism in which small RNAs trigger various forms of sequence-specific gene silencing by guiding Argonaute complexes to target RNAs by means of base pairing. RNA silencing is thought to have evolved as a form of nucleic-acid-based immunity to inactivate viruses and transposable elements. Although the activity of transposable elements in animals has been thought largely to be restricted to the germ line, recent studies have shown that they may also actively transpose in somatic cells, creating ... | |
|
Haematologica (9 February 2010), haematol.2009.017079.
Abstract10.3324/haematol.2009.017079 ... | |
|
Advanced Drug Delivery Reviews, Vol. 55, No. 4. (25 April 2003), pp. 519-548.
by C. Vauthier
AbstractThis review considers the use of poly(alkylcyanoacrylates) (PACAs) as biomedical materials. We first present the different aspects of the polymerization of alkylcyanoacrylate monomers and briefly discuss their applications as skin adhesives, surgical glues and embolitic materials. An extensive review of the developments and applications of PACAs as nanoparticles for the delivery of drugs is then given. The methods of preparation of the nanoparticles are presented and considerations concerning the degradation, in vivo distribution, toxicity and cytotoxicity of the nanoparticles are discussed. ... | |
|
In Cancer Microenvironment and Therapeutic Implications (2009), pp. 81-104.
by Gianfranco Baronzio, Isabel Freitas, Attilio Baronzio, Miriam Baronzio, Elisabetta Crespi, Paolo A. Netti
AbstractAbstract A drug to be effective must satisfy two important requirements. First, it must act on diseased tissue sparing healthy tissue, second it must reach target tissue at adequate concentration to perform its therapeutic effect. As reported by several authors, conventional cancer treatments do not achieve this aim, resulting in suboptimal activity and inability to eradicate tumor tissue. The reasons for this failure are multiple and partially due to the unique physiology of tumor tissue. Tumors develop drug barriers, including high ... | |
|
Clinical Cancer Research, Vol. 14, No. 5. (1 March 2008), pp. 1310-1316.
Abstract10.1158/1078-0432.CCR-07-1441 Cancer nanotherapeutics are rapidly progressing and are being implemented to solve several limitations of conventional drug delivery systems such as nonspecific biodistribution and targeting, lack of water solubility, poor oral bioavailability, and low therapeutic indices. To improve the biodistribution of cancer drugs, nanoparticles have been designed for optimal size and surface characteristics to increase their circulation time in the bloodstream. They are also able to carry their loaded active drugs to cancer cells by selectively using the unique pathophysiology of ... | |
|
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Vol. 1786, No. 2. (December 2008), pp. 126-138.
AbstractDuring the last decade, the potential of peptides for drug delivery into cells has been highlighted by the discovery of several cell-penetrating peptides (CPPs). CPPs are very efficient in delivering various molecules into cells. However, except in some specific cases, their lack of cell specificity remains the major drawback for their clinical development. At the same time, various peptides with specific binding activity for a given cell line (cell-targeting peptides) have also been reported in the literature. One of the goals ... | |
|
The International Journal of Biochemistry & Cell Biology, Vol. 37, No. 4. (April 2005), pp. 726-730.
by M. Bachmann, T. Moroy
AbstractThe human pim-1 gene encodes a serine/threonine kinase, which belongs to the group of calcium/calmodulin-regulated kinases (CAMK). It contains a characteristic kinase domain, a so-called ATP anchor and an active site. In mouse and human, two Pim-1 proteins are produced from the same gene by using an alternative upstream CUG initiation codon, a 44 kD and another, shorter 34 kD form that both contain the kinase domain. Expression of Pim-1 is widespread and ranges from the hematopoietic and lymphoid system to ... | |
|
PloS one, Vol. 4, No. 10. (2009)
by Alex N. Bullock, Santina Russo, Ann Amos, et al.Nicholas Pagano, Howard Bregman, Judit E. Debreczeni, Wen Hwa H. Lee, Frank von Delft, Eric Meggers, Stefan Knapp
AbstractBACKGROUND: The serine/threonine kinase PIM2 is highly expressed in human leukemia and lymphomas and has been shown to positively regulate survival and proliferation of tumor cells. Its diverse ATP site makes PIM2 a promising target for the development of anticancer agents. To date our knowledge of catalytic domain structures of the PIM kinase family is limited to PIM1 which has been extensively studied and which shares about 50% sequence identity with PIM2. PRINCIPAL FINDINGS: Here we determined the crystal structure of ... | |
|
The Journal of clinical investigation, Vol. 115, No. 10. (October 2005), pp. 2618-2624.
AbstractThe Akt and Pim kinases are cytoplasmic serine/threonine kinases that control programmed cell death by phosphorylating substrates that regulate both apoptosis and cellular metabolism. The PI3K-dependent activation of the Akt kinases and the JAK/STAT-dependent induction of the Pim kinases are examples of partially overlapping survival kinase pathways. Pharmacological manipulation of such kinases could have a major impact on the treatment of a wide variety of human diseases including cancer, inflammatory disorders, and ischemic diseases. ... | |
|
Blood, Vol. 109, No. 11. (1 June 2007), pp. 5011-5015.
AbstractPatients with advanced stages of chronic myeloid leukemia (CML) often manifest imatinib mesylate resistance associated with point mutations in BCR-ABL. AMN107 is a new higher-potency inhibitor of BCR-ABL. To identify mutations in BCR-ABL that could result in resistance to AMN107, a cDNA library of BCR-ABL mutants was introduced into Ba/F3 cells followed by selection in AMN107 (0.125-0.5 microM). A total of 86 individual, drug-resistant colonies were recovered, and the SH3, SH2, and kinase domains of BCR-ABL were sequenced. A total of ... | |
|
Pharmacology & Therapeutics, Vol. 93, No. 2-3. (March 2002), pp. 79-98.
by D. Fabbro
AbstractMany components of mitogenic signaling pathways in normal and neoplastic cells have been identified, including the large family of protein kinases, which function as components of signal transduction pathways, playing a central role in diverse biological processes, such as control of cell growth, metabolism, differentiation, and apoptosis. The development of selective protein kinase inhibitors that can block or modulate diseases caused by abnormalities in these signaling pathways is widely considered a promising approach for drug development. Because of their deregulation in ... | |
|
Chemistry & Biology, Vol. 13, No. 7. (July 2006), pp. 693-694.
| |
|
TARGETS, Vol. 2, No. 3. (01 June 2003), pp. 101-108.
by S. Buchanan
AbstractA plethora of important targets for therapeutic intervention occurs in the protein kinase superfamily, one of the most thoroughly investigated groups of drug targets. Kinases have a deep hydrophobic ATP binding site that has been successfully exploited with the discovery of potent ATP-competitive drugs. However, most features of this pocket are well conserved in all protein kinases, which explains why kinase inhibitors typically exhibit a fairly indiscriminate spectrum of activity. Crystal structures of various protein kinases bound to their ligands are ... | |
|
EMBO reports, Vol. 8, No. 10. (October 2007), pp. 914-919.
AbstractJust as people head to the beaches for a well-deserved rest, accumulating evidence suggests that transcription factors take similar 'vacations' at the nuclear envelope. Recent studies indicate that the periphery of the nucleus provides a platform for sequestering transcription factors away from chromatin. Several transcriptional regulators, operating in different signal-transduction pathways, have been found to interact physically with components of the inner nuclear membrane. In general, this association seems to restrict access to their target genes and limit their transactivation or ... | |
|
Journal of Cellular Physiology, Vol. 203, No. 2. (2005), pp. 319-327.
by Nadir M. Maraldi, Stefano Squarzoni, Patrizia Sabatelli, et al.Cristina Capanni, Elisabetta Mattioli, Andrea Ognibene, Giovanna Lattanzi
AbstractJust at the beginning of the millennium the neologism laminopathies has been introduced in the scientific vocabulary. An exponential increase of interest on the subject started concomitantly, so that a formerly quite neglected group of rare human diseases is now widely investigated. This review will cover the history of the identification of the molecular basis for fourteen (since now) hereditary diseases arising from defects in genes that encode nuclear envelope and nuclear lamina-associated proteins and will also consider the hypotheses that ... | |
|
Current Opinion in Cell Biology, Vol. 18, No. 3. (June 2006), pp. 335-341.
| |
|
Cellular and Molecular Life Sciences, Vol. 58, No. 12. (19 November 2001), pp. 1748-1757.
AbstractAbstract: The nuclear lamins polymerize to form the nuclear lamina, a fibrous structure found on the inner face of the nuclear membrane. The lamins also appear to form structures within the nucleoplasm. These various lamin structures help to establish and maintain the shape and strength of the interphase nucleus, but recent work also suggests that the lamins have a role in nuclear processes such as DNA replication. Furthermore, mutations in the human lamin A/C gene have recently been linked to several ... | |
|
Journal of Structural Biology, Vol. 129, No. 2-3. (April 2000), pp. 313-323.
by Y. Gruenbaum
AbstractThe nuclear lamina is located between the inner nuclear membrane and the peripheral chromatin. It is composed of both peripheral and integral membrane proteins, including lamins and lamina-associated proteins. Lamins can interact with one another, with lamina-associated proteins, with nuclear scaffold proteins, and with chromatin. Likewise, most of the lamina-associated proteins are likely to interact directly with chromatin. The nuclear lamina is required for proper cell cycle regulation, chromatin organization, DNA replication, cell differentiation, and apoptosis. Mutations in proteins of the ... | |
|
Surface and Interface Analysis, Vol. 33, No. 2. (2002), pp. 118-121.
AbstractAtomic force microscopy (AFM) has been used in situ to study the topography and mechanical properties of red blood cells. When imaging the surface of the blood cells in topographic mode, the underlying cytoskeleton of the cell could be observed. This is a result of the different compressibility of the cell, depending on whether the underlying cytoskeleton is under the tip, which would be relatively hard, or just the cell membrane, which would be soft. The modulation technique confirms that the ... | |
|
Ultramicroscopy, Vol. 86, No. 1-2. (January 2001), pp. 107-112.
by M O'Reilly,
AbstractFor humans the sizes and shapes of their red blood cells are important indicators of well being. In this study, the feasibility of using the atomic force microscope (AFM) to provide the sizes and shapes of red blood cells has been investigated. An immobilisation procedure has been developed that enabled red blood cells to be reliably imaged by contact AFM in air. The shapes of the red blood cells were readily apparent in the AFM images. Various cell quantification parameters were ... | |
|
Expert opinion on drug delivery, Vol. 6, No. 12. (1 December 2009), pp. 1261-1282.
AbstractIn recent years, with the widespread application of high-throughput screening technologies in drug discovery, an increasing number of new chemical entities with extremely poor aqueous solubility have been generated. Their poor solubility represents a major challenge for formulation of these compounds for both oral and parenteral administration. Formulations for intravenous (i.v.) application are of significant importance because they are frequently used in several key therapeutic areas, such as oncology and anesthesia. Furthermore, i.v. formulations of new compounds are often needed to ... | |
|
Science, Vol. 323, No. 5921. (20 March 2009), pp. 1564-1565.
Abstract10.1126/science.1168451 ... | |
|
Journal of Tissue Engineering and Regenerative Medicine, Vol. 2, No. 4. (2008), pp. 169-183.
AbstractStem cells have the capacity for self-renewal and capability of differentiation to various cell lineages. Thus, they represent an important building block for regenerative medicine and tissue engineering. These cells can be broadly classified into embryonic stem cells (ESCs) and non-embryonic or adult stem cells. ESCs have great potential but their use is still limited by several ethical and scientific considerations. The use of bone marrow-, umbilical cord-, adipose tissue-, skin- and amniotic fluid-derived mesenchymal stem cells might be an adequate ... | |
|
N Engl J Med, Vol. 349, No. 6. (7 August 2003), pp. 570-582.
posted by
2 people
LeilaA
LeilaRosen
Abstract10.1056/NEJMra022361 ... | |
|
Endocr Rev, Vol. 30, No. 3. (1 May 2009), pp. 204-213.
AbstractStem cell research offers great promise for understanding basic mechanisms of human development and differentiation, as well as the hope for new treatments for diseases such as diabetes, spinal cord injury, Parkinson's disease, and myocardial infarction. However, human stem cell (hSC) research also raises sharp ethical and political controversies. The derivation of pluripotent stem cell lines from oocytes and embryos is fraught with disputes about the onset of human personhood. The reprogramming of somatic cells to produce induced pluripotent stem cells ... | |
|
J. Cell Biol., Vol. 184, No. 1. (12 January 2009), pp. 45-55.
posted by
3 people
LeilaA
kokphinchooi
chiufanlee
AbstractInteraction of lamins with chromatin and transcription factors regulate transcription. Oct-1 has previously been shown to colocalize partly with B-type lamins and is essential for transcriptional regulation of oxidative stress response genes. Using sequential extraction, co-immunoprecipitation (IP), fluorescence loss in photobleaching, and fluorescence resonance energy transfer, we confirm Oct-1-lamin B1 association at the nuclear periphery and show that this association is lost in Lmnb1Delta/Delta cells. We show that several Oct-1-dependent genes, including a subset involved in oxidative stress response, are dysregulated ... | |
|
Pharmacology & Therapeutics, Vol. 82, No. 2-3. (June 1999), pp. 195-206.
by P. Traxler
posted by
2 people
LeilaA
GermanErlenkamp
AbstractProtein tyrosine kinases play a fundamental role in signal transduction pathways. Deregulated tyrosine kinase activity has been observed in many proliferative diseases (e.g., cancer, psoriasis, restenosis, etc.). Tyrosine kinases are, therefore, attractive targets for the design of new therapeutic agents against cancer. We have built up a pharmacophore model of the ATP-binding site of the epidermal growth factor receptor (EGFR) kinase and used it for the rational design of kinase inhibitors. Several examples of the successful use of this model are ... | |
|
J Appl Physiol, Vol. 106, No. 2. (1 February 2009), pp. 506-512.
posted by
2 people
LeilaA
LeilaRosen
AbstractMechanical stimulus is a regulator of tenocyte metabolism. The present study investigated temporal regulation of the expression of selected genes by tenocytes in isolated fascicles subjected to tensile strain in vitro. Cyclic tensile strain with a 3% amplitude superimposed on a 2% static strain was provided for 10 min, followed by either an unstrained period or continuous cyclic strain until the end of a 24-h incubation period. mRNA expression of selected anabolic and catabolic genes were evaluated with quantitative PCR at ... | |
|
Current Opinion in Chemical Biology, Vol. 12, No. 1. (February 2008), pp. 40-45.
AbstractStructural genomics (SG) has significantly increased the number of novel protein structures of targets with medical relevance. In the protein kinase area, SG has contributed >50% of all novel kinases structures during the past three years and determined more than 30 novel catalytic domain structures. Many of the released structures are inhibitor complexes and a number of them have identified new inhibitor binding modes and scaffolds. In addition, generated reagents, assays, and inhibitor screening data provide a diversity of chemogenomic data ... | |
|
Advances in Enzyme Regulation, Vol. 49, No. 1. (2009), pp. 157-166.
| |
|
Stem Cell Reviews and Reports, Vol. 5, No. 2. (1 June 2009), pp. 96-101.
AbstractAbstract Since its early days, stem cell research, particularly human embryonic stem cell research, has been the focus of intense social debate, and the question of the moral status of the embryo has been a central issue in the controversy. Despite this friction, and while it has yet to obtain widespread success in clinical applications, stem cell research remains a great hope for future advances in healthcare. In this paper, we will discuss the results of our systematic literature review in which ... | |
|
Current Opinion in Cell Biology, Vol. 21, No. 2. (April 2009), pp. 280-287.
posted by
4 people
LeilaA
structural_bioinformatics
McCammon
barry
| |
|
Genes & Development, Vol. 22, No. 7. (1 April 2008), pp. 832-853.
by Thomas Dechat, Katrin Pfleghaar, Kaushik Sengupta, et al.Takeshi Shimi, Dale K. Shumaker, Liliana Solimando, Robert D. Goldman
Abstract10.1101/gad.1652708 Over the past few years it has become evident that the intermediate filament proteins, the types A and B nuclear lamins, not only provide a structural framework for the nucleus, but are also essential for many aspects of normal nuclear function. Insights into lamin-related functions have been derived from studies of the remarkably large number of disease-causing mutations in the human lamin A gene. This review provides an up-to-date overview of the functions of nuclear lamins, emphasizing their roles in ... | |
|
Proceedings of the National Academy of Sciences, Vol. 105, No. 1. (8 January 2008), pp. 180-185.
by Naama Wiesel, Anna Mattout, Shai Melcer, et al.Naomi Melamed-Book, Harald Herrmann, Ohad Medalia, Ueli Aebi, Yosef Gruenbaum
posted by
4 people
LeilaA
thegoose2
C. elegans / WormBase
tharris
Abstract10.1073/pnas.0708974105 Lamins are nuclear intermediate filament proteins and the major building blocks of the nuclear lamina. Besides providing nuclear shape and mechanical stability, lamins are required for chromatin organization, transcription regulation, DNA replication, nuclear assembly, nuclear positioning, and apoptosis. Mutations in human lamins cause many different heritable diseases, affecting various tissues and causing early aging. Although many of these mutations result in nuclear deformation, their effects on lamin filament assembly are unknown. has a single evolutionarily conserved lamin protein, which ... | |
|
Journal of Controlled Release, Vol. 126, No. 3. (20 March 2008), pp. 187-204.
AbstractNanotechnology has shown tremendous promise in target-specific delivery of drugs and genes in the body. Although passive and active targeted-drug delivery has addressed a number of important issues, additional properties that can be included in nanocarrier systems to enhance the bioavailability of drugs at the disease site, and especially upon cellular internalization, are very important. A nanocarrier system incorporated with stimuli-responsive property (e.g., pH, temperature, or redox potential), for instance, would be amenable to address some of the systemic and intracellular ... | |
|
Oncogene, Vol. 27, No. 35. (28 April 2008), pp. 4809-4819.
AbstractPim kinases are found to be highly expressed in leukemia, lymphoma, prostate and pancreatic cancer. Bitransgenic mice overexpressing either Pim-1 or Pim-2 and c-Myc succumb to pre-B-cell lymphoma at a strikingly accelerated speed. Despite that Pim-1|[sol]|Pim-2 has long been recognized as a strong synergistic partner with c-Myc in tumorigenesis, the mechanism underlying the synergism is still not well understood. Overexpression of Pim-1|[sol]|Pim-2 kinase dramatically stabilizes c-Myc in vivo, and the stabilization is partially mediated by phosphorylation of c-Myc by Pim ... | |
|
Nature Reviews Drug Discovery, Vol. 7, No. 3. (01 February 2008), pp. 255-270.
by Jarkko Rautio, Hanna Kumpulainen, Tycho Heimbach, et al.Reza Oliyai, Dooman Oh, Tomi Jarvinen, Jouko Savolainen
posted by
3 people
LeilaA
jrhill
middledomain
AbstractProdrugs are bioreversible derivatives of drug molecules that undergo an enzymatic and/or chemical transformation in vivo to release the active parent drug, which can then exert the desired pharmacological effect. In both drug discovery and development, prodrugs have become an established tool for improving physicochemical, biopharmaceutical or pharmacokinetic properties of pharmacologically active agents. About 5–7% of drugs approved worldwide can be classified as prodrugs, and the implementation of a prodrug approach in the early stages of drug discovery is a growing ... | |
|
Nat Rev Drug Discov, Vol. 7, No. 2. (01 February 2008), pp. 131-142.
posted by
3 people
LeilaA
LeilaRosen
psique
| |
|
Proceedings of the National Academy of Sciences, Vol. 104, No. 51. (18 December 2007), pp. 20523-20528.
by Oleg Fedorov, Brian Marsden, Vanda Pogacic, et al.Peter Rellos, Susanne Müller, Alex N. Bullock, Juerg Schwaller, Michael Sundström, Stefan Knapp
posted by
7 people
LeilaA
kokphinchooi
pauldobson
tmmurali
cjeans
renatomilani
guhjy
Abstract10.1073/pnas.0708800104 Protein kinases play a pivotal role in cell signaling, and dysregulation of many kinases has been linked to disease development. A large number of kinase inhibitors are therefore currently under investigation in clinical trials, and so far seven inhibitors have been approved as anti-cancer drugs. In addition, kinase inhibitors are widely used as specific probes to study cell signaling, but systematic studies describing selectivity of these reagents across a panel of diverse kinases are largely lacking. Here we evaluated the ... | |
|
Nature Reviews Genetics, Vol. 7, No. 12. (01 December 2006), pp. 940-952.
AbstractFew genes have generated as much recent interest as LMNA, LMNB1 and LMNB2, which encode the components of the nuclear lamina. Over 180 mutations in these genes are associated with at least 13 known diseases — the laminopathies. In particular, the study of LMNA, its products and the phenotypes that result from its mutation have provided important insights into subjects ranging from transcriptional regulation, the cell biology of the nuclear lamina and mechanisms of ageing. Recent studies have begun the difficult ... | |
|
Journal of Biological Chemistry, Vol. 280, No. 50. (16 December 2005), pp. 41675-41682.
Abstract10.1074/jbc.M510711200 The Pim kinases are a family of three vertebrate protein serine/threonine kinases (Pim-1, -2, and -3) belonging to the CAMK (calmodulin-dependent protein kinase-related) group. Pim kinases are emerging as important mediators of cytokine signaling pathways in hematopoietic cells, and they contribute to the progression of certain leukemias and solid tumors. A number of cytoplasmic and nuclear proteins are phosphorylated by Pim kinases and may act as their effectors in normal physiology and in disease. Recent crystallographic studies of Pim-1 have ... | |
|
Drug Discovery Today, Vol. 10, No. 12. (15 June 2005), pp. 839-846.
posted by
4 people
LeilaA
kokphinchooi
tjimenez
kuhn
AbstractThe annotation and visualization of medicinally relevant kinase space revealed that kinase inhibitors in the clinic are, on average, of higher molecular weight and more lipophilic than all other clinically investigated drugs. Tyrosine kinases from the vascular endothelial growth factor and epidermal growth factor receptor families are the most pursued targets. Furthermore, oncological indications account for 75% of all kinase-related clinical interest. In addition, analysis of the similarity between kinase targets with respect to sequence, selectivity and structure has revealed that ... | |
|
Science, Vol. 303, No. 5665. (19 March 2004), pp. 1818-1822.
posted by
5 people
LeilaA
jame0taylor
Jch88
mcc19732001
monkare
AbstractDrug delivery systems (DDS) such as lipid- or polymer-based nanoparticles can be designed to improve the pharmacological and therapeutic properties of drugs administered parenterally. Many of the early problems that hindered the clinical applications of particulate DDS have been overcome, with several DDS formulations of anticancer and antifungal drugs now approved for clinical use. Furthermore, there is considerable interest in exploiting the advantages of DDS for in vivo delivery of new drugs derived from proteomics or genomics research and for their ... | |
|
Nature Reviews Cancer, Vol. 2, No. 10. (01 October 2002), pp. 750-763.
posted by
3 people
LeilaA
vesriram
Tumor-Immunology
AbstractCytotoxic chemotherapy or radiotherapy of cancer is limited by serious, sometimes life-threatening, side effects that arise from toxicities to sensitive normal cells because the therapies are not selective for malignant cells. So how can selectivity be improved? One strategy is to couple the therapeutics to antibodies or other ligands that recognize tumour-associated antigens. This increases the exposure of the malignant cells, and reduces the exposure of normal cells, to the ligand-targeted therapeutics. ... | |
|
Clinical Pharmacology & Therapeutics, Vol. 85, No. 5. (01 May 2009), pp. 451-455.
AbstractOnce evidence exists that a particular chemical entity positively affects a disease state and possesses a reasonable safety profile, proper treatment comes from adjusting the dose to appropriately minimize the risks and maximize the benefits of the therapeutic entity. With knowledge of environmental and/or genetic factors, physicians and other health-care practitioners commonly make dosage adjustments tailored to best meet an individual patient’s needs. ... | |
|
Trends in Biochemical Sciences, Vol. 26, No. 7. (1 July 2001), pp. 438-444.
by A. Ishijima
posted by
2 people
saradtc
isaacturner
AbstractIn recent years, the rapid development and progress of single-molecule detection techniques have opened up a new era of biological research. The advantage of single-molecule studies is that data are not obscured by the ensemble-averaged measurements inherent in classical biochemical experiments. These techniques are shedding light on the dynamic and mechanistic properties of molecular machines, both in vivo and in vitro . This review summarizes the single-molecule experiments that have been designed to investigate molecular motors, enzyme reactions, protein dynamics, DNA ... | |
|
Trends in Biochemical Sciences, Vol. 9, No. 7. (July 1984), pp. 322-328.
by J. Shriver
posted by
2 people
saradtc
isaacturner
AbstractIt is now generally believed that the force necessary for muscle contraction results from a structural transition in the myosin crossbridge. Recent spectroscopic studies have indicated that myosin can exist in two distinct structural states. The equilibrium between the two states is poised in such a way that it can be forced in either direction with minor changes in experimental conditions. During ATP hydrolysis, myosin is forced to oscillate between the two states concomitantly with free energy dissipation. The chemical energy ... | |
|
Current Biology, Vol. 13, No. 16. (19 August 2003), pp. 1409-1413.
AbstractFeedback inhibition of gene expression is a widespread phenomenon in which the expression of a gene is downregulated by its protein product. Feedback in eukaryotic cells involves time delays resulting from transcription, transcript splicing and processing, and protein synthesis. In principle, such delays can result in oscillatory mRNA and protein expression [1] . However, experimental evidence of such delay-driven oscillations has been lacking. Using mathematical modeling informed by recent data, I show that the observed oscillatory expression and activity of ... | |
|
Nature, Vol. 388, No. 6640. (24 July 1997), pp. 386-390.
posted by
3 people
saradtc
isaacturner
fkowald
AbstractKinesin is a two-headed, ATP-dependent motor protein1, 2 that moves along microtubules indiscrete steps3 of 8 nm. In vitro, single molecules produceprocessive movement4, 5, motors typically take 100steps before releasing from a microtubule5, 6, 7 . A central question relates tomechanochemical coupling in this enzyme: how many molecules ofATP are consumed per step? For the actomyosin system,experimental approaches to this issue have generated considerablecontroversy8, 9. Here we take advantage of theprocessivity of kinesin to determine the coupling ratio withoutrecourse to ... | |
|
Journal of Medicinal Chemistry, Vol. 47, No. 27. (1 December 2004), pp. 6658-6661.
by Louis J. Lombardo, Francis Y. Lee, Ping Chen, et al.Derek Norris, Joel C. Barrish, Kamelia Behnia, Stephen Castaneda, Lyndon A. M. Cornelius, Jagabandhu Das, Arthur M. Doweyko, Craig Fairchild, John T. Hunt, Ivan Inigo, Kathy Johnston, Amrita Kamath, David Kan, Herbert Klei, Punit Marathe, Suhong Pang, Russell Peterson, Sidney Pitt, Gary L. Schieven, Robert J. Schmidt, John Tokarski, Mei-Li Wen, John Wityak, Robert M. Borzilleri
AbstractA series of substituted 2-(aminopyridyl)- and 2-(aminopyrimidinyl)thiazole-5-carboxamides was identified as potent Src/Abl kinase inhibitors with excellent antiproliferative activity against hematological and solid tumor cell lines. Compound 13 was orally active in a K562 xenograft model of chronic myelogenous leukemia (CML), demonstrating complete tumor regressions and low toxicity at multiple dose levels. On the basis of its robust in vivo activity and favorable pharmacokinetic profile, 13 was selected for additional characterization for oncology indications. ... | |
|
ChemBioChem, Vol. 6, No. 3. (2005), pp. 455-459.
AbstractNo Abstract ... | |
|
Journal of Medicinal Chemistry, Vol. 50, No. 3. (1 February 2007), pp. 409-424.
AbstractPMID: 17266192 ... | |
|
N Engl J Med, Vol. 354, No. 24. (15 June 2006), pp. 2531-2541.
by Moshe Talpaz, Neil P. Shah, Hagop Kantarjian, et al.Nicholas Donato, John Nicoll, Ron Paquette, Jorge Cortes, Susan O'Brien, Claude Nicaise, Eric Bleickardt, M. Anne Blackwood-Chirchir, Vishwanath Iyer, Tai-Tsang Chen, Fei Huang, Arthur P. Decillis, Charles L. Sawyers
AbstractBackground The BCR-ABL tyrosine kinase inhibitor imatinib is effective in Philadelphia chromosome-positive (Ph-positive) leukemias, but relapse occurs, mainly as a result of the outgrowth of leukemic subclones with imatinib-resistant BCR-ABL mutations. We evaluated dasatinib, a BCR-ABL inhibitor that targets most imatinib-resistant BCR-ABL mutations, in patients with chronic myelogenous leukemia (CML) or Ph-positive acute lymphoblastic leukemia (ALL). Methods Patients with various phases of CML or with Ph-positive ALL who could not tolerate or were resistant to imatinib were enrolled in a ... | |
|
Blood, Vol. 109, No. 6. (15 March 2007), pp. 2303-2309.
by Andreas Hochhaus, Hagop M. Kantarjian, Michele Baccarani, et al.Jeffrey H. Lipton, Jane F. Apperley, Brian J. Druker, Thierry Facon, Stuart L. Goldberg, Francisco Cervantes, Dietger Niederwieser, Richard T. Silver, Richard M. Stone, Timothy P. Hughes, Martin C. Muller, Rana Ezzeddine, Athena M. Countouriotis, Neil P. Shah
AbstractAlthough imatinib induces marked responses in patients with chronic myeloid leukemia (CML), resistance is increasingly problematic, and treatment options for imatinib-resistant or -intolerant CML are limited. Dasatinib, a novel, highly potent, oral, multitargeted kinase inhibitor of BCR-ABL and SRC family kinases, induced cytogenetic responses in a phase 1 study in imatinib-resistant or -intolerant CML and was well tolerated. Initial results are presented from a phase 2 study of 186 patients with imatinib-resistant or -intolerant chronic-phase CML (CML-CP) designed to further establish ... | |
|
Quarterly Reviews of Biophysics, Vol. 42, No. 01. (2009), pp. 1-40.
AbstractProtein kinases catalyse key phosphorylation reactions in signalling cascades that affect every aspect of cell growth, differentiation and metabolism. The kinases have become prime targets for drug intervention in the diseased state, especially in cancer. There are currently 10 drugs that have been approved for clinical use and many more in clinical trials. This review summarises the structural basis for protein kinase inhibition and discusses the mode of action for each of the approved drugs in the light of structural results. ... | |
|
Circulation, Vol. 109, No. 10. (16 March 2004), pp. 1196-1205.
AbstractProtein kinases are enzymes that covalently modify proteins by attaching phosphate groups (from ATP) to serine, threonine, and/or tyrosine residues. In so doing, the functional properties of the protein kinase's substrates are modified. Protein kinases transduce signals from the cell membrane into the interior of the cell. Such signals include not only those arising from ligand-receptor interactions but also environmental perturbations such as when the membrane undergoes mechanical deformation (ie, cell stretch or shear stress). Ultimately, the activation of signaling pathways ... | |
|
Proceedings of the National Academy of Sciences, Vol. 104, No. 35. (28 August 2007), pp. 14074-14079.
by Nicole H. Purcell, Benjamin J. Wilkins, Allen York, et al.Marc K. Saba-El-Leil, Sylvain Meloche, Jeffrey Robbins, Jeffery D. Molkentin
Abstract10.1073/pnas.0610906104 MAPK signaling pathways function as critical regulators of cellular differentiation, proliferation, stress responsiveness, and apoptosis. One branch of the MAPK signaling pathway that culminates in ERK1/2 activation is hypothesized to regulate the growth and adaptation of the heart to both physiologic and pathologic stimuli, given its known activation in response to virtually every stress- and agonist-induced hypertrophic stimulus examined to date. Here we investigated the requirement of ERK1/2 signaling in mediating the cardiac hypertrophic growth response in and mice, as ... | |
|
Physiology, Vol. 22, No. 5. (01 October 2007), pp. 328-334.
| |
|
Blood, Vol. 113, No. 5. (29 January 2009), pp. 1184-1191.
by Kallal Pramanik, Chang Z. Chun, Maija K. Garnaas, et al.Ganesh V. Samant, Keguo Li, Mark A. Horswill, Paula E. North, Ramani Ramchandran
AbstractMitogen-activated protein kinases play an integral role in several cellular processes. To regulate mitogen-activated protein kinases, cells express members of a counteracting group of proteins called phosphatases. In this study, we have identified a specific role that one member of this family of phosphatases, dual-specific phosphatase-5 (Dusp-5) plays in vascular development in vivo. We have determined that dusp-5 is expressed in angioblasts and in established vasculature and that it counteracts the function of a serine threonine kinase, Snrk-1, which also plays ... | |
|
British Journal of Pharmacology, Vol. 157, No. 4. (2009), pp. 551-553.
AbstractVascular ATP-sensitive potassium (KATP) channels (Kir6.1/SUR2B) are regulated by both cell metabolism and chemical transmitters. They are the target for a number of vasodilators and vasoconstrictors whose mechanisms of action involve activation of protein kinase A (PKA) and protein kinase C (PKC), respectively. The article by Orie et al. in this issue of the BJP sheds new light on the (opposing) role of protein phosphatases in the regulation of this ion channel activity. Their data suggest that calcineurin, a Ca2+-dependent protein phosphatase, ... | |
|
Physiology, Vol. 23, No. 1. (01 February 2008), pp. 6-16.
| |
|
Cardiovasc Res, Vol. 77, No. 4. (1 March 2008), pp. 649-658.
by Nazha Hamdani, Viola Kooij, Sabine van Dijk, et al.Daphne Merkus, Walter J. Paulus, Cris Remedios, Dirk J. Duncker, Ger J. M. Stienen, Jolanda van der Velden
AbstractSarcomeric dysfunction plays a central role in reduced cardiac pump function in heart failure. This review focuses on the alterations in sarcomeric proteins in diseased myocardium that range from altered isoform expression to post-translational protein changes such as proteolysis and phosphorylation. Recent studies in animal models of heart failure and human failing myocardium converge and indicate that sarcomeric dysfunction, including altered maximum force development, Ca2+ sensitivity, and increased passive stiffness, largely originates from altered protein phosphorylation, caused by neurohumoral-induced alterations in ... | |
|
Circulation, Vol. 117, No. 11. (18 March 2008), pp. 1423-1435.
by Maria I. Kontaridis, Wentian Yang, Kendra K. Bence, et al.Darragh Cullen, Bo Wang, Natalya Bodyak, Qingen Ke, Aleksander Hinek, Peter M. Kang, Ronglih Liao, Benjamin G. Neel
AbstractBackground-- Heart failure is the leading cause of death in the United States. By delineating the pathways that regulate cardiomyocyte function, we can better understand the pathogenesis of cardiac disease. Many cardiomyocyte signaling pathways activate protein tyrosine kinases. However, the role of specific protein tyrosine phosphatases (PTPs) in these pathways is unknown. Methods and Results-- Here, we show that mice with muscle-specific deletion of Ptpn11, the gene encoding the SH2 domain-containing PTP Shp2, rapidly develop a compensated dilated cardiomyopathy without ... | |
|
Cellular Signalling, Vol. 20, No. 8. (August 2008), pp. 1564-1577.
by Stephen J. Fuller, Sampsa Pikkarainen, El L. Tham, et al.Timothy E. Cullingford, Jeffery D. Molkentin, Hauke Cornils, Alexander Hergovich, Brian A. Hemmings, Angela Clerk, Peter H. Sugden
AbstractThe nuclear Dbf2-related protein kinases 1 and 2 (NDR1/2) are closely-related AGC family kinases that are strongly conserved through evolution. In mammals, they are activated inter alia by phosphorylation of an hydrophobic domain threonine-residue [NDR1(Thr-444)/NDR2(Thr-442)] by an extrinsic protein kinase followed by autophosphorylation of a catalytic domain serine-residue [NDR1(Ser-281)/NDR2(Ser-282)]. We examined NDR1/2 expression and regulation in primary cultures of neonatal rat cardiac myocytes and in perfused adult rat hearts. In myocytes, transcripts for NDR2, but not NDR1, were induced ... | |
|
Cardiovasc Res, Vol. 80, No. 1. (1 October 2008), pp. 47-54.
by Karl-Otto Larsen, Birgitte Lygren, Ivar Sjaastad, et al.Kurt A. Krobert, Kristin Arnkvaern, Geir Florholmen, Ann-Kristin R. Larsen, Finn O. Levy, Kjetil Tasken, Ole H. Skjonsberg, Geir Christensen
AbstractAimsChronic obstructive pulmonary disease with alveolar hypoxia is associated with diastolic dysfunction in the right and left ventricle (LV). LV diastolic dysfunction is not caused by increased afterload, and we recently showed that reduced phosphorylation of phospholamban at serine (Ser) 16 may explain the reduced relaxation of the myocardium. Here, we study the mechanisms leading to the hypoxia-induced reduction in phosphorylation of phospholamban at Ser16. Methods and resultsIn C57Bl/6j mice exposed to 10% oxygen, signalling molecules were measured in cardiac ... | |
|
Hypertension, Vol. 51, No. 6. (1 June 2008), pp. 1474-1475.
Abstract10.1161/HYPERTENSIONAHA.108.112144 ... | |
|
Journal of Biological Chemistry, Vol. 283, No. 45. (7 November 2008), pp. 31246-31255.
by Marjorie Maillet, Nicole H. Purcell, Michelle A. Sargent, Allen J. York, Orlando F. Bueno, Jeffery D. Molkentin
Abstract10.1074/jbc.M806085200 The strength and duration of mitogen-activated protein kinase signaling is regulated through phosphorylation and dephosphorylation by dedicated dual-specificity kinases and phosphatases, respectively. Here we investigated the physiological role that extracellular signal-regulated kinases 1/2 (ERK1/2) dephosphorylation plays through targeted disruption of the gene encoding dual-specificity phosphatase 6 () in the mouse. mice, which were viable, fertile, and otherwise overtly normal, showed an increase in basal ERK1/2 phosphorylation in the heart, spleen, kidney, brain, and fibroblasts, but no change in ... | |
|
Nat Rev Drug Discov, Vol. 1, No. 4. (01 April 2002), pp. 309-315.
by Philip Cohen
posted by
3 people
saradtc
kokphinchooi
TimRooney
AbstractProtein phosphorylation regulates most aspects of cell life, whereas abnormal phosphorylation is a cause or consequence of disease. A growing interest in developing orally active protein-kinase inhibitors has recently culminated in the approval of the first of these drugs for clinical use. Protein kinases have now become the second most important group of drug targets, after G-protein-coupled receptors. Here, I give a personal view of some of the most important advances that have shaped this field. ... | |
|
Science, Vol. 326, No. 5949. (2 October 2009), pp. 74-748.
AbstractReferential models based on extant African apes have dominated reconstructions of early human evolution since Darwin's time. These models visualize fundamental human behaviors as intensifications of behaviors observed in living chimpanzees and/or gorillas (for instance, upright feeding, male dominance displays, tool use, culture, hunting, and warfare). Ardipithecus essentially falsifies such models, because extant apes are highly derived relative to our last common ancestors. Moreover, uniquely derived hominid characters, especially those of locomotion and canine reduction, appear to have emerged shortly after ... | |
|
Acta Physiologica, Vol. 196, No. 1. (2009), pp. 37-53.
AbstractOver the past decade, AMP-activated protein kinase (AMPK) has emerged as an important intracellular signalling pathway in the heart. Activated AMPK stimulates the production of ATP by regulating key steps in both glucose and fatty acid metabolism. It has an inhibitory effect on cardiac protein synthesis. AMPK also interacts with additional intracellular signalling pathways in a coordinated network that modulates essential cellular processes in the heart. Evidence is accumulating that AMPK may protect the heart from ischaemic injury and limit the ... | |
|
BMC Systems Biology, Vol. 2, No. 1. (2008), 75.
AbstractBACKGROUND:In individual living cells p53 has been found to be expressed in a series of discrete pulses after DNA damage. Its negative regulator Mdm2 also demonstrates oscillatory behaviour. Attempts have been made recently to explain this behaviour by mathematical models but these have not addressed explicit molecular mechanisms. We describe two stochastic mechanistic models of the p53/Mdm2 circuit and show that sustained oscillations result directly from the key biological features, without assuming complicated mathematical functions or requiring more than one feedback ... | |
|
Journal of Muscle Research and Cell Motility, Vol. 29, No. 6. (1 December 2008), pp. 189-201.
by Nazha Hamdani, Monique de Waard, Andrew Messer, et al.Nicky Boontje, Viola Kooij, Sabine van Dijk, Amanda Versteilen, Regis Lamberts, Daphne Merkus, Cris dos Remedios, Dirk Duncker, Attila Borbely, Zoltan Papp, Walter Paulus, Ger Stienen, Steven Marston, Jolanda van der Velden
AbstractAbstract In healthy human myocardium a tight balance exists between receptor-mediated kinases and phosphatases coordinating phosphorylation of regulatory proteins involved in cardiomyocyte contractility. During heart failure, when neurohumoral stimulation increases to compensate for reduced cardiac pump function, this balance is perturbed. The imbalance between kinases and phosphatases upon chronic neurohumoral stimulation is detrimental and initiates cardiac remodelling, and phosphorylation changes of regulatory proteins, which impair cardiomyocyte function. The main signalling pathway involved in enhanced cardiomyocyte contractility during increased cardiac load is the ... | |
|
Molecular Systems Biology, Vol. 2 (13 June 2006)
by Naama Geva-Zatorsky, Nitzan Rosenfeld, Shalev Itzkovitz, et al.Ron Milo, Alex Sigal, Erez Dekel, Talia Yarnitzky, Yuvalal Liron, Paz Polak, Galit Lahav, Uri Alon
posted by
3 people
TimRooney
saradtc
cryptochrome
AbstractUnderstanding the dynamics and variability of protein circuitry requires accurate measurements in living cells as well as theoretical models. To address this, we employed one of the best-studied protein circuits in human cells, the negative feedback loop between the tumor suppressor p53 and the oncogene Mdm2. We measured the dynamics of fluorescently tagged p53 and Mdm2 over several days in individual living cells. We found that isogenic cells in the same environment behaved in highly variable ways following DNA-damaging gamma irradiation: ... | |
|
Nature, Vol. 388, No. 6640. (24 July 1997), pp. 390-393.
AbstractA key goal in the study of the function of ATP-driven motor enzymes is to quantify the movement produced from consumption of one ATP molecule1, 2, 3. Discrete displacements of the processive motor kinesin along a microtubule have been reported as 5 and/or 8 nm (refs 4, 5). However, analysis of nanometre-scale movements is hindered by superimposed brownian motion. Moreover, because kinesin is processive and turns over stochastically, some observed displacements must arise from summation of smaller movements that are too ... | |
|
Trends in Biochemical Sciences, Vol. 30, No. 6. (June 2005), pp. 286-290.
| |
|
Nat Biotech, Vol. 26, No. 1. (08 January 2008), pp. 127-132.
by Mazen W. Karaman, Sanna Herrgard, Daniel K. Treiber, et al.Paul Gallant, Corey E. Atteridge, Brian T. Campbell, Katrina W. Chan, Pietro Ciceri, Mindy I. Davis, Philip T. Edeen, Raffaella Faraoni, Mark Floyd, Jeremy P. Hunt, Daniel J. Lockhart, Zdravko V. Milanov, Michael J. Morrison, Gabriel Pallares, Hitesh K. Patel, Stephanie Pritchard, Lisa M. Wodicka, Patrick P. Zarrinkar
| |
|
Nature Clinical Practice Oncology, Vol. 3, No. 8. (01 August 2006), pp. 448-457.
AbstractThere has been considerable progress in the systemic treatment of cancer because of the rapid development and clinical application of molecular targeted agents. Although patients with a particular type and stage of cancer are often treated as a single group, more-specific therapy is being considered, as subsets of these patients who are more likely to benefit from treatment with particular agents are being identified. We previously introduced the concept of 'oncogene addiction' to explain how some cancers that contain multiple genetic, ... | |
|
Nature Reviews Molecular Cell Biology, Vol. 2, No. 9. (01 September 2001), pp. 669-677.
AbstractATP synthase can be thought of as a complex of two motors — the ATP-driven F1 motor and the proton-driven Fo motor — that rotate in opposite directions. The mechanisms by which rotation and catalysis are coupled in the working enzyme are now being unravelled on a molecular scale. ... | |
|
Current Opinion in Cell Biology, Vol. 15, No. 2. (April 2003), pp. 221-231.
by J. Tyson
posted by
11 people
saradtc
tomd66
TimRooney
Dangerfc
bioNetwork_sysBio
joseph_x_zhou
Borelli
dolchan
cryptochrome
oelemento
bayesian
AbstractThe physiological responses of cells to external and internal stimuli are governed by genes and proteins interacting in complex networks whose dynamical properties are impossible to understand by intuitive reasoning alone. Recent advances by theoretical biologists have demonstrated that molecular regulatory networks can be accurately modeled in mathematical terms. These models shed light on the design principles of biological control systems and make predictions that have been verified experimentally. ... | |
|
Nature Biotechnology, Vol. 24, No. 10. (10 September 2006), pp. 1285-1292.
AbstractData analysis and interpretation remain major logistical challenges when attempting to identify large numbers of protein phosphorylation sites by nanoscale reverse-phase liquid chromatography/tandem mass spectrometry (LC-MS/MS) (Supplementary Figure 1 online). In this report we address challenges that are often only addressable by laborious manual validation, including data set error, data set sensitivity and phosphorylation site localization. We provide a large-scale phosphorylation data set with a measured error rate as determined by the target-decoy approach, we demonstrate an approach to maximize data ... | |
|
Trends in Genetics, Vol. 22, No. 10. (12 October 2006), pp. 545-554.
AbstractProtein phosphorylation affects most, if not all, cellular activities in eukaryotes and is essential for cell proliferation and development. An estimated 30% of cellular proteins are phosphorylated, representing the phosphoproteome, and phosphorylation can alter a protein's function, activity, localization and stability. Recent studies for large-scale identification of phosphosites using mass spectrometry are revealing the components of the phosphoproteome. The development of new tools, such as kinase assays using modified kinases or protein microarrays, enables rapid kinase substrate identification. The dynamics of ... | |
|
Nature, Vol. 441, No. 7092. (24 May 2006), pp. 457-462.
AbstractThe emergence of tumour-specific, molecularly targeted agents signifies a paradigm shift in cancer therapy, with less reliance on drugs that non-discriminately kill tumour and host cells. Although the diversity of targets giving rise to this new generation of anticancer drugs has expanded, many challenges persist in the design of effective treatment regimens. The complex interplay of signal-transduction pathways further complicates the customization of cancer treatments to target single mechanisms. However, despite uncertainty over precise or dominant mechanisms of action, especially for ... | |
|
Science, Vol. 303, No. 5665. (19 March 2004), pp. 1800-1805.
posted by
9 people
kokphinchooi
saradtc
guhjy
Yanno
tjimenez
aqeel
kummerj
superpyrin
nigham
AbstractProtein kinases are targets for treatment of a number of diseases. This review focuses on kinase inhibitors that are in the clinic or in clinical trials and for which structural information is available. Structures have informed drug design and have illuminated the mechanism of inhibition. We review progress with the receptor tyrosine kinases (growth factor receptors EGFR, VEGFR, and FGFR) and nonreceptor tyrosine kinases (Bcr-Abl), where advances have been made with cancer therapeutic agents such as Herceptin and Gleevec. Among the ... | |
|
Nature Biotechnology, Vol. 23, No. 3. (13 February 2005), pp. 329-336.
by Miles A. Fabian, William H. Biggs, Daniel K. Treiber, et al.Corey E. Atteridge, Mihai D. Azimioara, Michael G. Benedetti, Todd A. Carter, Pietro Ciceri, Philip T. Edeen, Mark Floyd, Julia M. Ford, Margaret Galvin, Jay L. Gerlach, Robert M. Grotzfeld, Sanna Herrgard, Darren E. Insko, Michael A. Insko, Andiliy G. Lai, Jean-Michel Lelias, Shamal A. Mehta, Zdravko V. Milanov, Anne M. Velasco, Lisa M. Wodicka, Hitesh K. Patel, Patrick P. Zarrinkar, David J. Lockhart
posted by
9 people
kokphinchooi
saradtc
Yanno
BragilMassoud
tjimenez
kuhn
7ofAnn
seowu
hchmani
AbstractKinase inhibitors show great promise as a new class of therapeutics. Here we describe an efficient way to determine kinase inhibitor specificity by measuring binding of small molecules to the ATP site of kinases. We have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clinical development, against a panel of 119 protein kinases. We find that specificity varies widely and is not strongly correlated with chemical structure or the identity of the intended target. Many novel interactions ... |





